This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Maxim Temnikov: Innovator in Diabetes Treatment
Introduction
Maxim Temnikov is an innovative inventor based in the United States. He has made significant contributions to the field of diabetes treatment, particularly focusing on Type I diabetes. His work aims to improve the quality of life for those affected by this chronic condition.
Latest Patents
Although Maxim Temnikov currently holds 0 patents, he has developed a noteworthy patent titled "Composition And Method For The Treatment Of Type I Diabetes." This method involves administering a therapeutically effective amount of 64Zn-enriched zinc to treat Type I diabetes. His research highlights the potential of zinc in managing this challenging disease.
Career Highlights
Throughout his career, Maxim Temnikov has dedicated himself to advancing medical treatments. His innovative approach to diabetes management showcases his commitment to improving patient outcomes. His research has garnered attention in the medical community, emphasizing the importance of novel treatment methods.
Collaborations
Maxim has collaborated with notable coworkers, including Peter Y Novak and Oleksandr Balakin. These partnerships have contributed to the development of his research and the exploration of new treatment avenues for diabetes.
Conclusion
Maxim Temnikov is a promising inventor whose work in diabetes treatment demonstrates the potential for innovative solutions in healthcare. His research on 64Zn-enriched zinc offers hope for those living with Type I diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile